Is Ozempic Right for You? What No One Is Telling Women as they Navigate Menopause
I am not here to vilify Ozempic. GLP-1 receptor agonists are real medications that produce real results, and for some women they are the right tool. But there is a conversation that is not happening loudly enough — particularly for women navigating perimenopause and early menopause — and I want to have it with you.
How GLP-1 Medications Work
Semaglutide (Ozempic, Wegovy) and similar medications work by mimicking a gut hormone called GLP-1 that is released after eating. They slow gastric emptying, suppress appetite, and improve insulin secretion. The result for many people is significant appetite reduction and, consequently, weight loss.
The mechanism is real. The weight loss is real. But weight loss is not the same as metabolic health — and in perimenopausal women, the distinction matters enormously.
What GLP-1 Medications Don't Address
Here is what semaglutide does not do:
It does not regulate cortisol. If chronic stress is driving visceral fat storage, the medication reduces appetite but leaves the underlying driver untouched.
It does not restore sleep architecture. The sleep disruption of perimenopause — driven by progesterone decline and cortisol dysregulation — continues.
It does not support estrogen detoxification. Impaired hormone clearance through the liver and gut contributes to estrogen dominance and inflammation during perimenopause.
It does not rebuild the gut microbiome. The estrobolome — the collection of gut bacteria responsible for metabolizing estrogen — is not addressed.
These are not small omissions. They are the root causes of why weight loss feels impossible for many women in this transition.
The Muscle Loss Problem
This is the part I feel most strongly about. Weight loss on GLP-1 medications is not purely fat loss. Studies consistently show that a meaningful percentage of weight lost on these medications is lean muscle mass.
For perimenopausal women, this is a serious concern. Muscle mass is your primary driver of resting metabolic rate. It is essential for bone density, which is already under hormonal pressure during this transition. It is protective against insulin resistance and cardiovascular disease. Losing it in the name of a lower number on the scale is a trade-off many women don't realize they're making.
A More Complete Alternative
What I offer in the Women's Body Composition Program is not a shortcut — I'll be honest about that. It asks more of you. But it also addresses the actual terrain: cortisol, sleep, hormone detoxification, gut health, and strategic movement designed to preserve and build muscle.
Women who go through this kind of work don't just lose weight. They feel different in their bodies. Their energy changes. Their mood stabilizes. Their relationship with food shifts. These are outcomes that a medication cannot produce on its own.
If you are considering GLP-1 medications, I encourage you to ask your prescribing provider about muscle preservation strategies, sleep support, and cortisol assessment. And if you want to explore what a root-cause approach looks like first, I'd love to talk.
→ Join the free webinar on April 23 at 6 pm PST
→ Learn about the Women's Body Composition Program
— Elizabeth Greenfield, RN, MS, IFMCP
The content on this blog is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Reading this content does not create a practitioner-client relationship. Always consult with a qualified healthcare provider before making changes to your diet, supplements, or health protocols. Individual results vary.
